Cartesian Therapeutics, Inc.: operating_income
| Value | {"amount": -143405000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | Cartesian Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:22:07.387048+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a65690aa-ffac-4e4d-98f8-45ed2aa763e4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001453687-26-000064Retrieved: 2026-08-19T14:22:07.387048+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001453687/operating-income/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a65690aa-ffac-4e4d-98f8-45ed2aa763e4
History
- no predecessors — first report